Real-World Insights

Facilitating physician feedback

Primary market research
Understand cancer care through market research using Challenging Cases®

These live and virtual interactive events provide insight into complex clinical decisions and patient challenges. Understanding how clinician behavior, awareness and perception influence decision making are critical to predicting trends and future product utilization among community oncologists.


Physician education programs
Creating differentiated education programs with Insight-Driven Education



Primary market research
See your product through physicians' eyes with Emerging Perspectives

Whether you're launching a new drug or have a new set of indications for an existing product, you need provider input regarding appropriate use and unforeseen challenges to adoption. Through our new Emerging Perspectives program, we'll assemble a panel of physicians to provide case-based feedback on your product using primary market research.
Before meeting, we'll conduct surveys to see how providers would typically respond to the scenarios you propose. Then we'll facilitate an in-person question and answer session to help the panel better understand your drug. Afterward, we'll conduct quantitative and qualitative assessments to see if product education affected providers' approaches. The results will help you identify barriers to adoption and refine your go-to-market strategy.
Talk to our team to understand how Emerging Perspectives can help you plan for the road ahead.


Community-based evidence programs
Pressure-test hypotheses prior to deeper research with Community-Based Evidence

When the physicians who prescribe your product observe an unexpected outcome in their patient population, you need to get to the bottom of the issue quickly. Community-Based Evidence evaluates a subset of practices to pressure-test hypotheses to see if they require further investigation.
We'll gather preliminary evidence into publication form for podium presentations or panel meetings, so that your organization can determine whether to pursue deeper real-world evidence generation. It's a simple way to ensure your research investments are prioritized wisely.
